NASDAQ:NEPH

Nephros (NEPH) Stock Price, News & Analysis

$2.36
+0.09 (+3.96%)
(As of 05/17/2024 ET)
Today's Range
$2.26
$2.55
50-Day Range
$1.99
$2.43
52-Week Range
$1.16
$4.04
Volume
60,155 shs
Average Volume
19,268 shs
Market Capitalization
$24.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

Nephros MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
111.9% Upside
$5.00 Price Target
Short Interest
Healthy
0.03% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.51mentions of Nephros in the last 14 days
Based on 8 Articles This Week
Insider Trading
Acquiring Shares
$112,000 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.01 out of 5 stars

Medical Sector

611th out of 922 stocks

Surgical & Medical Instruments Industry

69th out of 96 stocks

NEPH stock logo

About Nephros Stock (NASDAQ:NEPH)

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

NEPH Stock Price History

NEPH Stock News Headlines

Nephros (NASDAQ:NEPH) Stock Rating Reaffirmed by Benchmark
Nephros (NASDAQ:NEPH) Shares Up 0.5%
Nephros, Inc. (NEPH)
Nephros, Inc.'s (NASDAQ:NEPH) Profit Outlook
Nephros Full Year 2023 Earnings: Misses Expectations
Nephros just upgraded at Benchmark, here's why
Earnings Outlook For Nephros
Nephros earnings: here's what to expect
What Is Nephros, Inc.'s (NASDAQ:NEPH) Share Price Doing?
See More Headlines
Receive NEPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nephros and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/07/2024
Today
5/17/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NEPH
Employees
31
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+111.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-1,580,000.00
Pretax Margin
-10.23%

Debt

Sales & Book Value

Annual Sales
$14.24 million
Book Value
$0.78 per share

Miscellaneous

Free Float
10,112,000
Market Cap
$24.87 million
Optionable
Not Optionable
Beta
1.24
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Robert Banks (Age 49)
    President, CEO & Director
    Comp: $474.04k
  • Ms. Judy F. Krandel C.F.A. (Age 59)
    Chief Financial Officer
    Comp: $147.01k
  • Mr. Alfred Vargas
    Director of Operations
  • Brianne McGuire
    Director of Brand, Marketing & Business Development
  • Vashone R. Thomas
    Vice President of Quality, Regulatory, & Human Resources
  • Mr. Daron G. Evans M.B.A. (Age 50)
    M.S., Chief Executive Officer of Specialty Renal Products, Inc
    Comp: $300.18k
  • Mr. Greg Lucas
    President of Aether Water Systems
  • Ms. Judy Mazzini
    Controller

NEPH Stock Analysis - Frequently Asked Questions

Should I buy or sell Nephros stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nephros in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NEPH shares.
View NEPH analyst ratings
or view top-rated stocks.

What is Nephros' stock price target for 2024?

1 brokers have issued twelve-month target prices for Nephros' shares. Their NEPH share price targets range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 111.9% from the stock's current price.
View analysts price targets for NEPH
or view top-rated stocks among Wall Street analysts.

How have NEPH shares performed in 2024?

Nephros' stock was trading at $3.46 at the beginning of the year. Since then, NEPH shares have decreased by 31.8% and is now trading at $2.36.
View the best growth stocks for 2024 here
.

When is Nephros' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our NEPH earnings forecast
.

How were Nephros' earnings last quarter?

Nephros, Inc. (NASDAQ:NEPH) released its quarterly earnings results on Thursday, March, 7th. The company reported ($0.06) earnings per share for the quarter. The company earned $3.25 million during the quarter. Nephros had a negative trailing twelve-month return on equity of 17.01% and a negative net margin of 10.23%.

Who are Nephros' major shareholders?

Nephros' stock is owned by a number of institutional and retail investors. Top institutional investors include Mesirow Financial Investment Management Inc. (0.15%). Insiders that own company stock include Andrew Astor, Robert R Jr Banks, Tom Gwydir and Wesley S Lobo.
View institutional ownership trends
.

How do I buy shares of Nephros?

Shares of NEPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NEPH) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners